Deutsche Bank upgraded GlaxoSmithKline (NYSE: GSK) from Hold to Buy. Analyst Mark Clark believes risk/reward s now positive.

This article: 112 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE